SELENOP
Selenoprotein P
Also known as: SELP, SeP, SEPP, SEPP1, SEPP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49908
- Gene
- SELENOP
- Ensembl
- ENSG00000250722
- Chromosome
- 5
- Canonical length
- 381 aa
- Protein class
- Plasma proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Connecting piece
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a selenoprotein that is predominantly expressed in the liver and secreted into the plasma. This selenoprotein is unique in that it contains multiple selenocysteine (Sec) residues per polypeptide (10 in human), and accounts for most of the selenium in plasma. It has been implicated as an extracellular antioxidant, and in the transport of selenium to extra-hepatic tissues via apolipoprotein E receptor-2 (apoER2). Mice lacking this gene exhibit neurological dysfunction, suggesting its importance in normal brain function. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. The mRNA for this selenoprotein contains two SECIS elements. The use of alternative polyadenylation sites, one located in between the two SECIS elements, results in two populations of mRNAs containing either both (predominant) or just the upstream SECIS element (PMID:27881738). Alternatively spliced transcript variants have also been found for this gene. [provided by RefSeq, Oct 2018]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>P49908|SELENOP
1 MWRSLGLALA LCLLPSGGTE SQDQSSLCKQ PPAWSIRDQD PMLNSNGSVT VVALLQASUY
61 LCILQASKLE DLRVKLKKEG YSNISYIVVN HQGISSRLKY THLKNKVSEH IPVYQQEENQ
121 TDVWTLLNGS KDDFLIYDRC GRLVYHLGLP FSFLTFPYVE EAIKIAYCEK KCGNCSLTTL
181 KDEDFCKRVS LATVDKTVET PSPHYHHEHH HNHGHQHLGS SELSENQQPG APNAPTHPAP
241 PGLHHHHKHK GQHRQGHPEN RDMPASEDLQ DLQKKLCRKR CINQLLCKLP TDSELAPRSU
301 CCHCRHLIFE KTGSAITUQC KENLPSLCSU QGLRAEENIT ESCQURLPPA AUQISQQLIP
361 TEASASURUK NQAKKUEUPS NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SELENOP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 5,860 nTPM
Expression across tissuesHPA
Tissue
- liver: 5,860 nTPM
- small intestine: 1,966 nTPM
- placenta: 913 nTPM
- spleen: 894 nTPM
- spinal cord: 884 nTPM
- kidney: 797 nTPM
Single-cell type
- enterocytes: 6,545 nCPM
- kupffer cells: 3,992 nCPM
- hepatocytes: 3,669 nCPM
- hofbauer cells: 1,840 nCPM
- macrophages: 1,396 nCPM
- colonocytes: 1,223 nCPM
Immune cell
- plasmacytoid DC: 0.9 nTPM
- MAIT T-cell: 0.6 nTPM
- NK-cell: 0.6 nTPM
- eosinophil: 0.5 nTPM
- gdT-cell: 0.5 nTPM
- naive B-cell: 0.5 nTPM
Brain region
- medulla oblongata: 955 nTPM
- white matter: 909 nTPM
- cerebellum: 649 nTPM
- basal ganglia: 548 nTPM
- pons: 532 nTPM
- midbrain: 499 nTPM
ReferencesPubMed · IEDB
Publications for SELENOP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone.
2023 · Redox Biol · RCR 3.6 · 22 citations - Natural Autoimmunity to Selenoprotein P Impairs Selenium Transport in Hashimoto's Thyroiditis.
2021 · Int J Mol Sci · RCR 1.8 · 22 citations - Autoimmunity to selenoprotein P predicts breast cancer recurrence.
2022 · Redox Biol · RCR 1.4 · 15 citations - Selenium Status in Paediatric Patients with Neurodevelopmental Diseases.
2022 · Nutrients · RCR 0.5 · 4 citations - New-onset autoantibodies to selenoprotein P following severe burn injury.
2024 · Front Immunol · RCR 0.4 · 2 citations
Show 2 more
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.32
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- locomotory behavior
- post-embryonic development
- regulation of growth
- response to oxidative stress
- response to selenium ion
- selenium compound metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Selenoprotein P, N-terminal
- Selenoprotein P, C-terminal
- Selenoprotein P
- Selenoprotein P, N terminal region
- Selenoprotein P, C terminal region
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SELENOP as an antibody target. Whether an autoantibody or antibody against SELENOP could matter depends on whether native SELENOP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SELENOP is annotated as secreted, so native SELENOP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SELENOP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...